Treatment of Mycobacterium Xenopi Pulmonary Infection

NCT01298336 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Atypical; Mycobacterium, Pulmonary, Tuberculous

Interventions

DRUG: Clarithromycin
DRUG: Moxifloxacin

Sponsor

Centre Hospitalier Universitaire, Amiens